Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeineR A Mathôt, J M Gubbens-Stibbe, W Soudijn, et al.
Purinergic Signalling|October 21, 2015
Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptorsA Massink, M Holzheimer, A Hölscher, et al.
Journal of Lipid Research|February 20, 1998
Role of ceramide 1 in the molecular organization of the stratum corneum lipidsJ A Bouwstra, G S Gooris, F E Dubbelaar, et al.
European Journal of Pharmacology|November 22, 1997
Biological activities of N6,C8-disubstituted adenosine derivatives as partial agonists at rat brain adenosine A1 receptorsA Lorenzen, A M Sebastião, A Sellink, et al.
Biochemical Pharmacology|December 3, 1993
Characterization of ecto-ATPase on human blood cells. A physiological role in platelet aggregation?M W Beukers, I M Pirovano, A van Weert, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 1997
Mechanism-based pharmacokinetic-pharmacodynamic modeling of the effects of N6-cyclopentyladenosine analogs on heart rate in rat: estimation of in vivo operational affinity and efficacy at adenosine A1 receptorsP H Van Der Graaf, E A Van Schaick, R A Math-ot, et al.
Journal of Medicinal Chemistry|March 29, 1996
N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptorsH Roelen, N Veldman, A L Spek, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 9, 1998
Metabolic and cardiovascular effects of the adenosine A1 receptor agonist N6-(p-sulfophenyl)adenosine in diabetic Zucker rats: influence of the disease on the selectivity of actionE A van Schaick, K P Zuideveld, H E Tukker, et al.
Molecular Pharmacology|May 1, 1997
Study of the interaction between aryloxypropanolamines and Asn386 in helix VII of the human 5-hydroxytryptamine1A receptorW Kuipers, R Link, P J Standaar, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of R- and S-N6-phenylisopropyladenosine in conscious normotensive ratsR A Mathôt, B C Van den Aarsen, W Soudijn, et al.
Pageof 14